MAXIM PHARMACEUTICALS ANNOUNCES 2004 SECOND QUARTER FINANCIAL RESULTS
MAXIM PHARMACEUTICALS ANNOUNCES 2004 SECOND QUARTER FINANCIAL RESULTS SAN DIEGO, Calif., May 4, 2004 -- Maxim Pharmaceuticals, Inc. (Nasdaq NM: MAXM, SSE: MAXM) today announced results for the quarter ended March 31, 2004, the second quarter of its fiscal year. The net loss applicable to common stock for the quarter totaled $8.9 million, or $0.32 per share, compared to a loss applicable to common stock of $11.0 million, or $0.47 per share, for the prior-year quarter. The net loss applicable to common stock for the six months ended March 31, 2004, totaled $18.8 million or $0.67 per share,